As demonstrated in chondrocytes isolated from osteoarthritis patients, pretreatment with isofraxidin prior to IL-1β could inhibit IL-1β-stimulated expression of iNOS and COX-2 that in turn blocked the production of nitric oxide (NO) and prostaglandin E2 (PGE2). This evidence concerns the gene IL1B and osteoarthritis.